BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $16,082,000 | +28.1% | 573,342 | +35.6% | 0.00% | 0.0% |
| Q3 2016 | $12,557,000 | +88.7% | 422,793 | +28.7% | 0.00% | +100.0% |
| Q2 2016 | $6,655,000 | +59.0% | 328,630 | +41.7% | 0.00% | 0.0% |
| Q1 2016 | $4,185,000 | -25.9% | 231,869 | +8.1% | 0.00% | 0.0% |
| Q4 2015 | $5,648,000 | +75.9% | 214,416 | +42.5% | 0.00% | 0.0% |
| Q3 2015 | $3,211,000 | -0.9% | 150,459 | +23.1% | 0.00% | 0.0% |
| Q2 2015 | $3,239,000 | – | 122,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |